Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tagtociclib (PF-07104091)
i
Other names:
PF-07104091, PF 07104091, PF07104091
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
CDK2 inhibitor
Related drugs:
‹
CYC065 (6)
BLU-222 (4)
INX-315 (2)
RGT-419B (2)
TQB3616 (2)
TG02 (2)
PF-06873600 (1)
AVZO-021 (0)
FN-1501 (0)
GW8510 (0)
PF-07224826 (0)
RLY-2139 (0)
SYH2043 (0)
TY-0540 (0)
NUV-422 (0)
CYC202 (0)
CYC065 (6)
BLU-222 (4)
INX-315 (2)
RGT-419B (2)
TQB3616 (2)
TG02 (2)
PF-06873600 (1)
AVZO-021 (0)
FN-1501 (0)
GW8510 (0)
PF-07224826 (0)
RLY-2139 (0)
SYH2043 (0)
TY-0540 (0)
NUV-422 (0)
CYC202 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
PF-07104091
Sensitive: C2 – Inclusion Criteria
PF-07104091
Sensitive
:
C2
PF-07104091
Sensitive: C2 – Inclusion Criteria
PF-07104091
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login